Published in Front Microbiol on September 10, 2013
A method to determine the duration of the eclipse phase for in vitro infection with a highly pathogenic SHIV strain. Sci Rep (2015) 0.83
Improving the estimation of the death rate of infected cells from time course data during the acute phase of virus infections: application to acute HIV-1 infection in a humanized mouse model. Theor Biol Med Model (2014) 0.78
Pandemic HIV-1 Vpu overcomes intrinsic herd immunity mediated by tetherin. Sci Rep (2015) 0.78
Animal model studies on viral infections. Front Microbiol (2014) 0.75
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (1995) 34.97
Viral dynamics in human immunodeficiency virus type 1 infection. Nature (1995) 28.54
Strategies for mitigating an influenza pandemic. Nature (2006) 25.20
HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science (1996) 21.81
HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science (1995) 18.40
Decay characteristics of HIV-1-infected compartments during combination therapy. Nature (1997) 13.68
Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science (1998) 10.43
Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol (2008) 10.02
Humanized mice in translational biomedical research. Nat Rev Immunol (2007) 8.83
Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy. N Engl J Med (1999) 7.07
Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy. Proc Natl Acad Sci U S A (2008) 6.70
Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell (2008) 6.37
Public health interventions and epidemic intensity during the 1918 influenza pandemic. Proc Natl Acad Sci U S A (2007) 5.90
Hepatitis C virus replication in mice with chimeric human livers. Nat Med (2001) 5.87
Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat Biotechnol (2007) 5.21
Modelling viral and immune system dynamics. Nat Rev Immunol (2002) 4.98
Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis. Lancet (1999) 4.36
A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo. J Virol (2003) 4.12
Viral dynamics in hepatitis B virus infection. Proc Natl Acad Sci U S A (1996) 4.02
Kinetics of influenza A virus infection in humans. J Virol (2006) 3.78
HIV chemotherapy. Nature (2001) 3.63
Re-emergence of HIV after stopping therapy. Nature (1999) 3.54
HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals. Science (2010) 3.29
The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza. Cell (2013) 3.19
Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life. Proc Natl Acad Sci U S A (2013) 2.79
Modelling how ribavirin improves interferon response rates in hepatitis C virus infection. Nature (2004) 2.74
Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature (1997) 2.63
Redefining the viral reservoirs that prevent HIV-1 eradication. Immunity (2012) 2.56
Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell-free virions from blood plasma. Nat Med (1999) 2.53
Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers. Infect Immun (1980) 2.42
Prospects for a vaccine against the hepatitis C virus. Nature (2005) 2.38
Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS. J Virol (2009) 2.37
Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase. AIDS (2007) 2.27
The dynamics of human cytomegalovirus replication in vivo. J Exp Med (1999) 2.19
A simian immunodeficiency virus-infected macaque model to study viral reservoirs that persist during highly active antiretroviral therapy. J Virol (2009) 2.10
CD8+ lymphocytes control viral replication in SIVmac239-infected rhesus macaques without decreasing the lifespan of productively infected cells. PLoS Pathog (2010) 1.99
Human immunodeficiency virus type 1 quasi species that rebound after discontinuation of highly active antiretroviral therapy are similar to the viral quasi species present before initiation of therapy. J Infect Dis (2000) 1.96
HIV-1 dynamics in vivo: implications for therapy. Nat Rev Microbiol (2003) 1.94
Second-phase hepatitis C virus RNA decline during telaprevir-based therapy increases with drug effectiveness: implications for treatment duration. Hepatology (2011) 1.87
Quantifying the early immune response and adaptive immune response kinetics in mice infected with influenza A virus. J Virol (2010) 1.80
Recruitment times, proliferation, and apoptosis rates during the CD8(+) T-cell response to lymphocytic choriomeningitis virus. J Virol (2001) 1.72
A perspective on modelling hepatitis C virus infection. J Viral Hepat (2010) 1.67
A dynamical model of human immune response to influenza A virus infection. J Theor Biol (2006) 1.67
Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses. PLoS Pathog (2010) 1.65
Analysis of hepatitis B viral load decline under potent therapy: complex decay profiles observed. Hepatology (2001) 1.65
Neuraminidase inhibitor resistance in influenza: assessing the danger of its generation and spread. PLoS Comput Biol (2007) 1.64
Mathematical model of antiviral immune response. III. Influenza A virus infection. J Theor Biol (1994) 1.62
Antiretroviral dynamics determines HIV evolution and predicts therapy outcome. Nat Med (2012) 1.61
Mathematical model of influenza A virus production in large-scale microcarrier culture. Biotechnol Bioeng (2005) 1.55
Cooperative effect of the attenuation determinants derived from poliovirus sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD/SCID mouse infection model. J Virol (2007) 1.54
Modeling amantadine treatment of influenza A virus in vitro. J Theor Biol (2008) 1.51
Modeling HIV persistence, the latent reservoir, and viral blips. J Theor Biol (2009) 1.49
In vivo CD8+ T-cell suppression of siv viremia is not mediated by CTL clearance of productively infected cells. PLoS Pathog (2010) 1.48
Determination of virus burst size in vivo using a single-cycle SIV in rhesus macaques. Proc Natl Acad Sci U S A (2007) 1.48
Animal models for the study of hepatitis C virus infection and related liver disease. Gastroenterology (2012) 1.47
An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys. J Virol (2007) 1.41
Characterization of the follicular dendritic cell reservoir of human immunodeficiency virus type 1. J Virol (2008) 1.40
Control of influenza virus gene expression: quantitative analysis of each viral RNA species in infected cells. J Biochem (1989) 1.33
Episomal viral cDNAs identify a reservoir that fuels viral rebound after treatment interruption and that contributes to treatment failure. PLoS Pathog (2011) 1.32
A review of mathematical models of influenza A infections within a host or cell culture: lessons learned and challenges ahead. BMC Public Health (2011) 1.27
Lymph nodes harbor viral reservoirs that cause rebound of plasma viremia in SIV-infected macaques upon cessation of combined antiretroviral therapy. Virology (2011) 1.26
Modeling subgenomic hepatitis C virus RNA kinetics during treatment with alpha interferon. J Virol (2009) 1.23
Remarkable lethal G-to-A mutations in vif-proficient HIV-1 provirus by individual APOBEC3 proteins in humanized mice. J Virol (2010) 1.22
Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics. J Theor Biol (2010) 1.22
Mathematical modeling of subgenomic hepatitis C virus replication in Huh-7 cells. J Virol (2006) 1.21
Influence of follicular dendritic cells on decay of HIV during antiretroviral therapy. Proc Natl Acad Sci U S A (2000) 1.20
The role of cells refractory to productive infection in acute hepatitis B viral dynamics. Proc Natl Acad Sci U S A (2007) 1.19
Population modeling of influenza A/H1N1 virus kinetics and symptom dynamics. J Virol (2010) 1.14
Vpu augments the initial burst phase of HIV-1 propagation and downregulates BST2 and CD4 in humanized mice. J Virol (2012) 1.14
Quantification of hepatitis B vaccine-induced antibodies as a predictor of anti-HBs persistence. Vaccine (1995) 1.12
Analysis of hepatitis C virus decline during treatment with the protease inhibitor danoprevir using a multiscale model. PLoS Comput Biol (2013) 1.12
A novel animal model of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in humanized mice. Blood (2011) 1.10
Avian-type receptor-binding ability can increase influenza virus pathogenicity in macaques. J Virol (2011) 1.09
Exploring the effect of biological delays in kinetic models of influenza within a host or cell culture. BMC Public Health (2011) 1.09
Infection dynamics and virus-induced apoptosis in cell culture-based influenza vaccine production-Flow cytometry and mathematical modeling. Vaccine (2009) 1.08
Mathematical modelling of HCV infection: what can it teach us in the era of direct-acting antiviral agents? Antivir Ther (2012) 1.07
Hepatitis C Viral Kinetics in the Era of Direct Acting Antiviral Agents and IL28B. Curr Hepat Rep (2011) 1.06
Quantification system for the viral dynamics of a highly pathogenic simian/human immunodeficiency virus based on an in vitro experiment and a mathematical model. Retrovirology (2012) 1.06
Modeling complex decay profiles of hepatitis B virus during antiviral therapy. Hepatology (2009) 1.05
Hepatitis C viral kinetics with the nucleoside polymerase inhibitor mericitabine (RG7128). Hepatology (2012) 1.04
Combination antiviral therapy for influenza: predictions from modeling of human infections. J Infect Dis (2012) 1.04
An accurate two-phase approximate solution to an acute viral infection model. J Math Biol (2009) 1.03
Treatment of hepatitis C virus infection with interferon and small molecule direct antivirals: viral kinetics and modeling. Crit Rev Immunol (2010) 1.02
Discussion: the Kermack-McKendrick epidemic threshold theorem. Bull Math Biol (1991) 1.01
Modeling the intracellular dynamics of influenza virus replication to understand the control of viral RNA synthesis. J Virol (2012) 1.00
The half-life of hepatitis B virions. Hepatology (2006) 0.98
Identifying viral parameters from in vitro cell cultures. Front Microbiol (2012) 0.95
Neuraminidase inhibitors for treatment of human and avian strain influenza: A comparative modeling study. J Theor Biol (2010) 0.94
The mouse is out of the bag: insights and perspectives on HIV-1-infected humanized mouse models. Exp Biol Med (Maywood) (2011) 0.93
Modeling the mechanisms of acute hepatitis B virus infection. J Theor Biol (2007) 0.92
Hepatitis C Viral Kinetics in Special Populations. Curr Hepat Rep (2008) 0.90
Comparison of cytotoxic T lymphocyte efficacy in acute and persistent lymphocytic choriomeningitis virus infection. Proc Biol Sci (2011) 0.89
Intracellular transactivation of HIV can account for the decelerating decay of virus load during drug therapy. Mol Syst Biol (2010) 0.89
Towards multiscale modeling of influenza infection. J Theor Biol (2013) 0.87
Hepatitis C virus: current concepts and future challenges. QJM (2011) 0.85
Quantification of the dynamics of enterovirus 71 infection by experimental-mathematical investigation. J Virol (2012) 0.85
Hepatitis C virus kinetics in chimeric mice during antiviral therapy. Hepatology (2007) 0.83
A predictive model of response to peginterferon ribavirin in chronic hepatitis C using classification and regression tree analysis. Hepatol Res (2010) 1.58
Nuclear sequestration of beta-subunits by Rad and Rem is controlled by 14-3-3 and calmodulin and reveals a novel mechanism for Ca2+ channel regulation. J Mol Biol (2005) 1.30
Add-on therapy with the DPP-4 inhibitor sitagliptin improves glycemic control in insulin-treated Japanese patients with type 2 diabetes mellitus. Endocr J (2013) 1.22
A new spore precipitator with polarized dielectric insulators for physical control of tomato powdery mildew. Phytopathology (2006) 1.20
Distinct effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 on insulin secretion and gut motility. Diabetes (2005) 1.16
Sulfonylurea and glinide reduce insulin content, functional expression of K(ATP) channels, and accelerate apoptotic beta-cell death in the chronic phase. Diabetes Res Clin Pract (2007) 1.06
Insufficient radiofrequency ablation therapy may induce further malignant transformation of hepatocellular carcinoma. Hepatol Int (2008) 1.04
Expression of pendrin and periostin in allergic rhinitis and chronic rhinosinusitis. Allergol Int (2012) 1.04
Relationship between carotid intima-media thickness and silent cerebral infarction in Japanese subjects with type 2 diabetes. Diabetes Care (2009) 1.00
A prospective randomized controlled trial of preoperative whole-liver chemolipiodolization for hepatocellular carcinoma. Dig Dis Sci (2012) 0.98
Possible link of pioglitazone with bladder cancer in Japanese patients with type 2 diabetes. Diabetes Res Clin Pract (2012) 0.97
Analysis of regulatory T cells and IgG4-positive plasma cells among patients of IgG4-related sclerosing cholangitis and autoimmune liver diseases. J Gastroenterol (2010) 0.96
Effects of pitavastatin on lipid profiles and high-sensitivity CRP in Japanese subjects with hypercholesterolemia: Kansai Investigation of Statin for Hyperlipidemic Intervention in Metabolism and Endocrinology (KISHIMEN) investigatars. J Atheroscler Thromb (2008) 0.92
Quantification of deaminase activity-dependent and -independent restriction of HIV-1 replication mediated by APOBEC3F and APOBEC3G through experimental-mathematical investigation. J Virol (2014) 0.89
Neuroticism relates to daytime wakefulness and sleep devaluation via high neurophysiological efficiency in the bilateral prefrontal cortex: a preliminary study. Psychophysiology (2014) 0.87
Expression analysis of the auxin efflux carrier family in tomato fruit development. Planta (2010) 0.87
Evaluation of quantitative portal venous, hepatic arterial, and total hepatic tissue blood flow using xenon CT in alcoholic liver cirrhosis-comparison with liver cirrhosis related to hepatitis C virus and nonalcoholic steatohepatitis. Alcohol Clin Exp Res (2009) 0.87
Sulfonylurea and non-sulfonylurea hypoglycemic agents: pharmachological properties and tissue selectivity. Diabetes Res Clin Pract (2004) 0.86
Pathophysiological analysis of nonalcoholic fatty liver disease by evaluation of fatty liver changes and blood flow using xenon computed tomography: can early-stage nonalcoholic steatohepatitis be distinguished from simple steatosis? J Gastroenterol (2012) 0.84
Transient evoked otoacoustic emissions in newborn infants: Effects of ear asymmetry, gender, and age. J Otolaryngol (2006) 0.84
A case of diabetic ketoacidosis associated with Guillain-Barré syndrome. Intern Med (2011) 0.83
Assessment of hepatic steatosis and hepatic tissue blood flow by xenon computed tomography in nonalcoholic steatohepatitis. Hepatol Res (2008) 0.83
Evaluation of quantitative portal venous, hepatic arterial, and total hepatic tissue blood flow using xenon CT in alcoholic liver cirrhosis: comparison with liver cirrhosis C. Alcohol Clin Exp Res (2007) 0.82
A case of sick building syndrome in a Japanese office worker. Ind Health (2005) 0.82
Effect of nucleoside analog-interferon sequential therapy on patients with acute exacerbation of chronic hepatitis B. Hepatol Res (2010) 0.81
Effect of high dietary fat on insulin secretion in genetically diabetic Goto-Kakizaki rats. Pancreas (2002) 0.81
The Eradication of Helicobacter pylori does not Affect Glycemic Control in Japanese Subjects with Type 2 Diabetes. Jpn Clin Med (2013) 0.80
Role of Vacuolar H+-inorganic pyrophosphatase in tomato fruit development. J Exp Bot (2012) 0.80
Determination of time-course change rate for arterial xenon using the time course of tissue xenon concentration in xenon-enhanced computed tomography. Med Phys (2008) 0.80
The Hearing Handicap Inventory for Elderly-Screening (HHIE-S) versus a single question: reliability, validity, and relations with quality of life measures in the elderly community, Japan. Qual Life Res (2012) 0.80
Efficacy of omalizumab in eosinophilic chronic rhinosinusitis patients with asthma. Ann Allergy Asthma Immunol (2013) 0.80
[Epidemiological survey of allergic diseases in first-year junior high school students in Wakayama Prefecture in 2003]. Nihon Jibiinkoka Gakkai Kaiho (2006) 0.80
Early-onset postirradiation sarcoma of the tongue after pseudotumor phase. ORL J Otorhinolaryngol Relat Spec (2011) 0.79
Hypovitaminosis D is frequent in Japanese subjects with type 2 diabetes. Diabetes Res Clin Pract (2006) 0.79
Xenon computed tomography can evaluate the improvement of hepatic hemodynamics before and after endoscopic injection sclerotherapy. J Gastroenterol (2013) 0.79
[Outcome of neonatal screening for hearing loss in neonatal intensive care unit and well-born nursery infants]. Nihon Jibiinkoka Gakkai Kaiho (2002) 0.79
Detection of ileal carcinoid tumor needs further investigations for other lesions. Am J Gastroenterol (2010) 0.79
Improving the estimation of the death rate of infected cells from time course data during the acute phase of virus infections: application to acute HIV-1 infection in a humanized mouse model. Theor Biol Med Model (2014) 0.78
Measurement of blood flow and xenon solubility coefficient in the human liver by xenon-enhanced computed tomography. Med Phys (2012) 0.78
Familial isolated stapes-pyramidal fixation by a bony bar with normal stapedius tendon. Arch Otolaryngol Head Neck Surg (2005) 0.78
[Three cases of liver abscess associated with the Streptococcus anginosus group]. Nihon Shokakibyo Gakkai Zasshi (2013) 0.78
The role of the TSC-22 (-396) A/G variant in the development of diabetic nephropathy. Diabetes Res Clin Pract (2003) 0.78
A case of lymphocytic panhypophysitis (LPH) during pregnancy. Endocrine (2007) 0.78
Mathematical modeling of multi-drugs therapy: a challenge for determining the optimal combinations of antiviral drugs. Theor Biol Med Model (2014) 0.78
Japanese cases of acute onset diabetic ketosis without acidosis in the absence of glutamic acid decarboxylase autoantibody. Endocrine (2010) 0.78
Uvulopalatopharyngoplasty decreases levels of C-reactive protein in patients with obstructive sleep apnea syndrome. Am Heart J (2006) 0.77
Induction of inducible nitric oxide synthase and apoptosis by LPS and TNF-alpha in nasal microvascular endothelial cells. Acta Otolaryngol (2008) 0.77
An evaluation of the clinical efficacy of tomato extract for perennial allergic rhinitis. Allergol Int (2007) 0.77
A novel locally operated master-slave robot system for single-incision laparoscopic surgery. Minim Invasive Ther Allied Technol (2014) 0.77
Quantitative multilevel mapping of hepatic blood flow by xenon computed tomography using aorta. J Comput Assist Tomogr (2003) 0.77
Less variation of R-R interval of electrocardiogram in nonobese type 2 diabetes with nocturnal intermittent hypoxia. Endocr J (2012) 0.77
Usefulness of serum cystatin C in Japanese patients with type 2 diabetes mellitus and nephropathy. Diabetes Res Clin Pract (2008) 0.76
A novel endoscopic papillectomy after a pancreatic stent placement above the pancreatic duct orifice: inside pancreatic stenting papillectomy. J Clin Gastroenterol (2014) 0.76
[Combined MTX.5-FU.CDGP for the treatment of head and neck cancer]. Gan To Kagaku Ryoho (2003) 0.76
Lymphocytic panhypophysitis: its clinical features in Japanese cases. Jpn Clin Med (2011) 0.75
A retrograde-viewing device or a transparent hood for improving colorectal adenoma detection. Gastrointest Endosc (2011) 0.75
[Docetaxel (TXT) and irinotecan (CPT-11) as a second-line chemotherapy for platinum-pretreated squamous cell carcinoma of the head and neck]. Gan To Kagaku Ryoho (2008) 0.75
Fatigue and Sleep Among Employees With Prospective Increase in Work Time Control: A 1-Year Observational Study With Objective Assessment. J Occup Environ Med (2016) 0.75
Pitavastatin reduces elevated IL-18 levels in Japanese subjects with hypercholesterolemia: sub-analysis of Kansai investigation of statin for hyperlipidemic intervention in metabolism and endocrinology (KISHIMEN). J Atheroscler Thromb (2010) 0.75
[Willingness to pay for Japanese cedar pollinosis: comparison between pollination and non-pollination seasons]. Arerugi (2004) 0.75
The limited usefulness of the treadmill test or a risk-guided approach in screening for asymptomatic coronary heart disease in Japanese patients with type 2 diabetes. Intern Med (2012) 0.75
[Regional comparison of patient-reported outcomes in Japanese cedar pollinosis]. Arerugi (2005) 0.75
[2001 survey of pollen in Wakayama City with a real-time pollen counter]. Nihon Jibiinkoka Gakkai Kaiho (2002) 0.75
Two cases of rupture of esophagogastric varices during the course of oxaliplatin-based chemotherapy for colorectal cancer. Nihon Shokakibyo Gakkai Zasshi (2014) 0.75
Platelet-activating factor (PAF) induced cytokine production and otitis media with effusion (OME) in the rat middle ear. Auris Nasus Larynx (2007) 0.75
Relationship between telmisartan dose and glycaemic control in Japanese patients with type 2 diabetes mellitus and hypertension: a retrospective study. Clin Drug Investig (2012) 0.75
[Impact of allergic rhinitis on work productivity: a pilot study]. Arerugi (2005) 0.75
[Multi-institute survey on actual conditions of urologic management for severe bladder dysfunction after hysterectomy]. Hinyokika Kiyo (2008) 0.75
Changes in levels of hepatitis B virus markers in patients positive for low-titer hepatitis B surface antigen. Hepatol Res (2012) 0.75
[Comparison of clinical efficacy and cost-quality of antihistamines in early treatment for Japanese cedar pollinosis]. Arerugi (2006) 0.75
[Management of patients with diabetes mellitus by using clinical path]. Nihon Rinsho (2012) 0.75
Alterations of growth, blood biochemical components and hormone profiles by intensified nutrition in growth retarded Japanese Black cattle. J Vet Med Sci (2010) 0.75
Effect of antihistamine eye drops on the conjunctival provocation test with Japanese cedar pollen allergen. Allergol Int (2006) 0.75
[Epidemic study of pet allergy in Wakayama Prefecture]. Nihon Jibiinkoka Gakkai Kaiho (2003) 0.75
Generation of rat induced pluripotent stem cells using a plasmid vector and possible application of a keratan sulfate glycan recognizing antibody in discriminating teratoma formation phenotypes. Biol Pharm Bull (2015) 0.75
Efficacy of a detector tube method in formaldehyde measurement. Ind Health (2003) 0.75
Corrigendum: Quantifying the Antiviral Effect of IFN on HIV-1 Replication in Cell Culture. Sci Rep (2015) 0.75
[Assessment of clinical usefulness of Eviprostat for benign prostatic hyperplasia--comparison of Eviprostat tablet with a formulation containing two-times more active ingredients]. Hinyokika Kiyo (2008) 0.75
Preparation for awakening: self-awakening vs. forced awakening preparatory hangs in the pre-awakening period. Int Rev Neurobiol (2010) 0.75
Detection of Portal Vein Stenosis by Technetium-99m-Diethylenetriaminepentaacetic Acid-Galactosyl Human Serum Albumin Liver Scintigraphy after Living-Donor Liver Transplantation. Hepatogastroenterology (2014) 0.75
[Effects of drug adherence on patient outcomes to early treatment for Japanese cedar pollinosis]. Arerugi (2004) 0.75
[A comparative study between real time monitor KH-3000 and conventional Durham sampler measuring airborne pollen]. Nihon Jibiinkoka Gakkai Kaiho (2005) 0.75